Amplification mechanisms for the enhancement of antigen-mediated mast cell activation

Immunologic Research

Volumn 43, Issue 1-3, 2009, Pages 15-24

  Gilfillan, Alasdair M ^a   Peavy, Richard D ^a   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antigen; Fc RI; IgE; KIT; Mast cells; SCF; Signaling

Indexed keywords

ANTIGEN; CYTOKINE; FC EPSILON RECEPTOR I; FC RECEPTOR; G PROTEIN COUPLED RECEPTOR; LAT PROTEIN; LAT2 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; STEM CELL FACTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANTIGEN PRESENTATION; CALCIUM MOBILIZATION; CELL ACTIVATION; CHEMOTAXIS; CYTOKINE PRODUCTION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; IMMUNITY; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RODENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; DEGRANULATION; IMMUNOLOGY; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DEGRANULATION; HUMANS; MAST CELLS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IGE; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 66549086165     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8046-9     Document Type: Review

References (43)

1. DD Metcalfe 2008 Mast cells and mastocytosis Blood 112 946 56 18684881 10.1182/blood-2007-11-078097 1:CAS:528:DC%2BD1cXpvVOks7g%3D
2. YA Mekori DD Metcalfe 2000 Mast cells in innate immunity Immunol Rev 173 131 40 10719674 10.1034/j.1600-065X.2000.917305.x 1:STN:280: DC%2BD3c7osVGrug%3D%3D (Pubitemid 30095217)
3. JS Marshall 2004 Mast-cell responses to pathogens Nat Rev Immunol 4 787 99 15459670 10.1038/nri1460 1:CAS:528:DC%2BD2cXotVSlsLc%3D (Pubitemid 39336295)
4. SJ Galli S Nakae M Tsai 2005 Mast cells in the development of adaptive immune responses Nat Immunol 6 135 42 15662442 10.1038/ni1158 1:CAS:528:DC%2BD2MXlvVKmsA%3D%3D (Pubitemid 40268194)
5. C Tkaczyk BM Jensen S Iwaki AM Gilfillan 2006 Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses Immunol Allergy Clin North Am 26 427 50 16931287 10.1016/j.iac.2006. 05.011 (Pubitemid 44247541)
6. 2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism J Immunol 165 6545 52 11086097 1:CAS:528:DC%2BD3cXosFOhsbw%3D
7. M Laffargue R Calvez P Finan A Trifilieff M Barbier F Altruda, et al. 2002 Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function Immunity 16 441 51 11911828 10.1016/S1074-7613(02)00282-0 1:CAS:528:DC%2BD38Xis1Wmsbs%3D (Pubitemid 34260921)
8. H Qiao MV Andrade FA Lisboa K Morgan MA Beaven 2006 FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells Blood 107 610 8 16174756 10.1182/blood-2005-06-2271 1:CAS:528:DC%2BD28Xms1eksQ%3D%3D (Pubitemid 43076385)
9. C Tkaczyk V Horejsi S Iwaki P Draber LE Samelson AB Satterthwaite, et al. 2004 NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcεRI aggregation Blood 104 207 14 15010370 10.1182/blood-2003-08-2769 1:CAS:528:DC%2BD2cXlslWgsLY%3D (Pubitemid 38879859)
10. TR Hundley AM Gilfillan C Tkaczyk MV Andrade DD Metcalfe MA Beaven 2004 Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells Blood 104 2410 7 15217825 10.1182/blood-2004-02-0631 1:CAS:528:DC%2BD2cXovVegt7c%3D (Pubitemid 39331841)
11. S Iwaki C Tkaczyk AB Satterthwaite K Halcomb MA Beaven DD Metcalfe AM Gilfillan 2005 Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by kit J Biol Chem 280 40261 70 16176929 10.1074/jbc.M506063200 1:CAS:528:DC%2BD2MXht1Gjs7rE (Pubitemid 41779164)
12. AM Gilfillan C Tkaczyk 2006 Integrated signalling pathways for mast-cell activation Nat Rev Immunol 6 218 30 16470226 10.1038/nri1782 1:CAS:528:DC%2BD28XhsleltLY%3D (Pubitemid 43290991)
13. J Rivera AM Gilfillan 2006 Molecular regulation of mast cell activation J Allergy Clin Immunol 117 1214 25 16750977 10.1016/j.jaci.2006.04.015 1:CAS:528:DC%2BD28XlsVaqt7w%3D (Pubitemid 43795719)
14. HS Kuehn AM Gilfillan 2007 G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation Immunol Lett 113 59 69 17919738 10.1016/j.imlet.2007.08.007 1:CAS:528:DC%2BD2sXhtF2iurnJ (Pubitemid 47562126)
15. HS Kuehn MA Beaven HT Ma MS Kim DD Metcalfe AM Gilfillan 2008 Synergistic activation of phospholipases Cγ and Cβ: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release Cell Signal 20 625 36 18207701 10.1016/j.cellsig.2007.11.016 1:CAS:528:DC%2BD1cXitVejsr8%3D
16. M Toda M Dawson T Nakamura PM Munro RM Richardson M Bailly SJ Ono 2004 Impact of engagement of FcεRI and CC chemokine receptor 1 on mast cell activation and motility J Biol Chem 279 48443 8 15337751 10.1074/jbc.M408725200 1:CAS:528:DC%2BD2cXptl2ms7s%3D (Pubitemid 39541002)
17. MR Woolhiser K Brockow DD Metcalfe 2004 Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a Clin Immunol 110 172 80 15003814 10.1016/j.clim.2003.11.007 1:CAS:528:DC%2BD2cXhvV2hs7k%3D (Pubitemid 38296707)
18. RT Venkatesha TE Berla AK Zaidi H Ali 2005 Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase Mol Immunol 42 581 7 15607817 10.1016/j.molimm.2004.09.009 1:CAS:528:DC%2BD2cXhtVyktr7K (Pubitemid 39655936)
19. PS Jolly M Bektas A Olivera C Gonzalez-Espinosa RL Proia J Rivera, et al. 2004 Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis J Exp Med 199 959 70 15067032 10.1084/jem.20030680 1:CAS:528:DC%2BD2cXjtVejur8%3D (Pubitemid 38481087)
20. XS Wang HY Lau 2006 Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors Allergy 61 503 6 16512814 10.1111/j.1398-9995.2006. 01043.x 1:CAS:528:DC%2BD28XksFCmtL4%3D (Pubitemid 43334121)
21. M Kulka L Alexopoulou RA Flavell DD Metcalfe 2004 Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3 J Allergy Clin Immunol 114 174 82 15241362 10.1016/j.jaci.2004.03.049 1:CAS:528:DC%2BD2cXlsVaqtbY%3D (Pubitemid 39005135)
22. SC Bischoff CA Dahinden 1992 c-kit ligand: a unique potentiator of mediator release by human lung mast cells J Exp Med 175 237 44 1370529 10.1084/jem.175.1.237 1:CAS:528:DyaK38XlslantQ%3D%3D
23. A Iemura M Tsai A Ando BK Wershil SJ Galli 1994 The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis Am J Pathol 144 321 8 7508684 1:CAS:528:DyaK2cXjtFKltL0%3D
24. NS Yee I Paek P Besmer 1994 Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice J Exp Med 179 1777 87 7515099 10.1084/jem.179.6.1777 1:CAS:528:DyaK2cXktVCjtrw%3D (Pubitemid 24155659)
25. YA Mekori CK Oh DD Metcalfe 1995 The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis Int Arch Allergy Immunol 107 136 8 7542059 1:CAS:528:DyaK2MXnsVWku70%3D
26. DD Metcalfe JA Mekori M Rottem 1995 Mast cell ontogeny and apoptosis Exp Dermatol 4 227 30 8528594 10.1111/j.1600-0625.1995.tb00250.x 1:STN:280:BymD38nnt10%3D
27. NW Lukacs SL Kunkel RM Strieter HL Evanoff RG Kunkel ML Key DD Taub 1996 The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation Blood 87 2262 8 8630386 1:CAS:528: DyaK28Xhs1Ckur0%3D
28. TJ Lin AD Befus 1997 Differential regulation of mast cell function by IL-10 and stem cell factor J Immunol 159 4015 23 9378991 1:CAS:528: DyaK2sXmvVSlurc%3D
29. E Gagari M Tsai CS Lantz LG Fox SJ Galli 1997 Differential release of mast cell interleukin-6 via c-kit Blood 89 2654 63 9108382 1:CAS:528: DyaK2sXisFCju7c%3D
30. C Tkaczyk MA Beaven SM Brachman DD Metcalfe AM Gilfillan 2003 The phospholipase C gamma 1-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase J Biol Chem 278 48474 84 13129935 10.1074/jbc.M301350200 1:CAS:528:DC%2BD3sXpt1GjtLg%3D (Pubitemid 37523303)
31. C Tkaczyk DD Metcalfe AM Gilfillan 2002 Determination of protein phosphorylation in FcεRI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions J Immunol Methods 268 239 43 12215392 10.1016/S0022-1759(02)00210-7 1:CAS:528:DC%2BD38Xms1yit7k%3D (Pubitemid 35246169)
32. S Iwaki BM Jensen AM Gilfillan 2007 Ntal/Lab/Lat2 Int J Biochem Cell Biol 39 868 73 17118694 10.1016/j.biocel.2006.10.018 1:CAS:528:DC%2BD2sXksFaisLk%3D (Pubitemid 46584826)
33. S Iwaki J Spicka C Tkaczyk BM Jensen Y Furumoto N Charles, et al. 2008 Kit- and FcεRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells Cell Signal 20 195 205 17993265 10.1016/j.cellsig.2007.10.013 1:CAS:528:DC%2BD2sXhtlGgsLvP (Pubitemid 350138381)
34. K Ali A Bilancio M Thomas W Pearce AM Gilfillan C Tkaczyk, et al. 2004 Essential role for the p110δ phosphoinositide 3-kinase in the allergic response Nature 431 1007 11 15496927 10.1038/nature02991 1:CAS:528: DC%2BD2cXoslSlt7w%3D (Pubitemid 39434424)
35. AC Fluckiger Z Li RM Kato MI Wahl HD Ochs R Longnecker, et al. 1998 Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation EMBO J 17 1973 85 9524120 10.1093/emboj/17.7.1973 1:CAS:528:DyaK1cXisV2kur4%3D (Pubitemid 28154527)
36. S Saitoh R Arudchandran TS Manetz W Zhang CL Sommers PE Love, et al. 2000 LAT is essential for FcεRI-mediated mast cell activation Immunity 12 525 35 10843385 10.1016/S1074-7613(00)80204-6 1:CAS:528:DC%2BD3cXjvFGitbc%3D
37. V Parravicini M Gadina M Kovarova S Odom C Gonzalez-Espinosa Y Furumoto, et al. 2002 Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation Nat Immunol 3 741 8 12089510 1:CAS:528:DC%2BD38Xls1Snurc%3D
38. SG Dann A Selvaraj G Thomas 2007 mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer Trends Mol Med 13 252 9 17452018 10.1016/j.molmed.2007.04.002 1:CAS:528:DC%2BD2sXmtVGgtb8%3D (Pubitemid 46836871)
39. MS Kim HS Kuehn DD Metcalfe AM Gilfillan 2008 Activation and function of the mTORC1 pathway in mast cells J Immunol 180 4586 95 18354181 1:CAS:528:DC%2BD1cXjsVKqsLs%3D
40. C Akin LM Scott CN Kocabas N Kushnir-Sukhov E Brittain P Noel DD Metcalfe 2007 Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis Blood 110 2331 3 17638853 10.1182/blood-2006-06-028100 1:CAS:528:DC%2BD2sXhtFCnsbzF (Pubitemid 47523152)
41. BM Jensen DD Metcalfe AM Gilfillan 2007 Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation Inflamm Allergy Drug Targets 6 57 62 17352689 10.2174/187152807780077255 1:CAS:528:DC%2BD2sXjtlWhsb8%3D
42. BM Jensen C Akin AM Gilfillan 2008 Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders Br J Pharmacol 154 1572 82 18500355 10.1038/bjp.2008.204 1:CAS:528: DC%2BD1cXps1Grur8%3D
43. BM Jensen MA Beaven S Iwaki DD Metcalfe AM Gilfillan 2008 Concurrent inhibition of kit- and FcεRI-mediated signaling: coordinated suppression of mast cell activation J Pharmacol Exp Ther 324 128 38 17925481 10.1124/jpet.107.125237 1:CAS:528:DC%2BD1cXhsF2iug%3D%3D (Pubitemid 350294172)